An At-The-Market (ATM) offering allows a company to sell shares continuously at prevailing market prices without fixed pricing or lock-up periods. This flexibility enables firms to raise capital as needed, often for operational expenses, R&D, or debt repayment. However, ATMs pose significant dilution risks to existing shareholders, as unlimited share issuance can erode ownership and equity value over time.
Tevogen Bio Holdings Inc. (TVGN) has an ATM program with $800 million in remaining capacity, according to its latest filing. This figure is staggering relative to TVGN’s current market cap of $33.1 million, meaning the ATM capacity is 2,415% of its market value. The program has no remaining shelf registration capacity, making it the company’s primary tool for equity fundraising.
Notably, TVGN’s ATM is categorized as "HIGH" risk due to its massive scale and the absence of cash runway visibility. The company also faces a 42.9% dilution risk from existing convertible shares (1.8 million shares), compounding potential equity dilution from the ATM.
TVGN’s financial health raises red flags. Its cash runway score is 40/100, and "months cash remaining" is listed as null, suggesting insufficient liquidity to fund operations without external financing. The ATM likely serves as a lifeline to avoid a liquidity crisis.
The company’s offering ability score is 62/100, indicating moderate confidence in its ability to execute fundraisers without triggering severe market backlash. However, the ATM’s $800 million capacity suggests aggressive reliance on equity financing, which could signal operational struggles or overly ambitious growth plans.
TVGN’s public float stands at 1.07 million shares, with institutional ownership at just 3.62% of the float. This low institutional presence may limit market stability, making the stock more susceptible to volatility from ATM activity.
While trading volume data is unavailable, the ATM’s $800 million capacity implies the company could issue shares at a rate that dwarfs its existing float. For context, if TVGN were to fully utilize the ATM, it could issue shares equivalent to 2,415% of its current market cap, severely diluting existing shareholders. The pace will depend on cash burn and market conditions, but even partial use could have catastrophic effects on equity value.
TVGN’s dilution risk is compounded by two factors:
Assuming the ATM is fully utilized, existing shareholders could face over 2,000% dilution relative to current market cap. This level of dilution would drastically reduce ownership percentages and potentially trigger a downward spiral in share price.
TVGN’s tracking data began on February 26, 2026, and no prior ATM activity is disclosed. This lack of historical data makes it difficult to assess the company’s track record with equity fundraisers. However, the sheer size of the current ATM program suggests it may be a new or expanded initiative, likely driven by acute financial pressures.
DilutionWatch monitors shelf registrations, ATM offerings, warrant exercises, and cash runway across thousands of public companies — updated daily from SEC filings.
Get Full Access — Free Trial →